Akari Therapeutics plc ADS (AKTX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Akari Therapeutics plc ADS, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$9.20
+7.23% today
Market cap
$20M
Overall quality
45/100
Kronos AI 30-day
−2.8%
1 of 8 simulated paths end higher
Akari Therapeutics plc ADS (AKTX) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $20M. It trades at $9.20, up 7.23% today. Its overall quality score is 45 out of 100, ranked against the whole US market. 3 analysts' average target of $25.50 implies +177.2% from today's price. Kronos AI's 30-day forecast is −2.8% (1 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $25.50 |
| Low – high | $19.50 – $30.00 |
| Analysts | 3 |
| Upside to average | +177.2% |
Kronos AI 30-day forecast
| Expected close | $8.34 (−2.8%) |
| Likely range | −10.9% … +0.8% |
| As of | 2026-10-27 |
1 of 8 simulated paths end higher.
Quality scores
| Profitability | 36 |
| Solvency | 56 |
| Growth | 42 |
| Overall | 45 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.